Your session is about to expire
← Back to Search
Multimodal Pain Management for Postoperative Pain
Study Summary
This trial seeks to reduce opioid usage in orthopaedic surgery patients by testing a new pain management protocol.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have chosen a specific way to manage my pain.I need surgery for a bone or joint injury.Severe injuries from multiple traumas.I do not have any severe illnesses that are not under control.The doctor will decide how to manage your pain during the study.I am 18 years old or older.You have been using drugs or drinking alcohol recently, which could affect how we measure your pain or control it.
- Group 1: Standard oral hydrocodone-acetaminophen post-op management
- Group 2: Multimodal pain post-op management (Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this trial currently open?
"According to clinicialtrials.gov, this clinical trial is actively enrolling participants. The first posting of the study was on May 17th 2021 and it has been recently edited as of January 9th 2023."
How many individuals have enrolled in the experiment thus far?
"Affirmative. Clinicaltrials.gov confirms that this investigation, initially posted on May 17th 2021, is currently recruiting patients. The aim is to recruit a total of 100 individuals from 1 distinct site for the trial's duration."
What potential risks should be considered with the implementation of a combined Ibuprofen/Acetaminophen/GABAPentin/0.25%Bupivacaine medication regimen for post-operative pain management?
"There is ample evidence demonstrating the safety of this post-operative pain management system, so it was awarded a score of 3."
Share this study with friends
Copy Link
Messenger